Professor Peter Cistulli holds the ResMed Chair in Sleep Medicine at the University of Sydney, where he leads the Sleep Research Theme within the multidisciplinary Charles Perkins Centre, and heads the Discipline of Sleep Medicine within the Faculty of Medicine and Health. He is also Clinical Director of the Centre for Sleep Health & Research in the Department of Respiratory and Sleep Medicine at Royal North Shore Hospital, Sydney. He is an active physician- researcher with 28 years’ experience in the fields of respiratory and sleep medicine. His thematic research has focused on the pathophysiology of Sleep-disordered Breathing, and novel approaches to therapy. He is a former president of the Australasian Sleep Association, and was recently awarded its Distinguished Achievement Award for exceptional contributions to sleep science and sleep health.
Professor Jean-Louis Pepin is an international expert in clinical and translational research on cardio metabolic consequences of chronic and intermittent hypoxia, sleep apnea, chronic obstructive pulmonary disease and chronic respiratory failure. He runs the French national registry of sleep apnea (> 110,000 subjects) and is involved in the European Sleep Apnea Database (ESADA). He participates on a regular basis in European and US thoracic society task forces (five in last three years). He has demonstrated capabilities both in academic positions and as a leader of huge national randomized controlled trials, transdisciplinary programs (see below) and EIT-Health European projects.
Professor Atul Malhotra is a board-certified pulmonologist, intensivist and Research chief of Pulmonary, Critical Care and Sleep Medicine. He is active clinically in pulmonary, critical care and sleep medicine. In the sleep clinic, he provides a full spectrum of diagnostic and therapeutic services to patients with sleep-related disorders, including sleep apnea, insomnia, restless leg syndrome, narcolepsy and sleep disorders associated with medical or psychiatric conditions. He has a special interest in the treatment of sleep apnea. Dr. Malhotra is the recent president of the American Thoracic Society. He has taught and presented his research on sleep-related disorders locally, regionally, nationally and internationally. He has published more than 300 original manuscripts in leading journals.
He is a principal- and co-investigator on numerous projects relating to sleep apnea and serves as an ad hoc reviewer for many leading journals including the New England Journal of Medicine, Mayo Clinic Proceedings, Sleep and the Journal of American Medical Association. To view a full list of his publications, visit PubMed. As a professor in the Department of Medicine, Dr. Malhotra is involved in training medical students, residents and fellows at UC San Diego School of Medicine. Before joining UC San Diego Health, Dr. Malhotra practiced pulmonary, critical care and sleep medicine at Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital. He also served as attending physician in intensive care at King Faisal Hospital in Rwanda. He was associate professor at Harvard Medical School and medical director of the Brigham and Women’s Hospital Sleep Disorders Research Program. Dr. Malhotra completed his fellowship training in pulmonary and critical care medicine at Harvard Medical School and a residency in internal medicine at the Mayo Clinic. He completed an internship at St. Thomas Medical Center in Akron, OH and received his medical degree from the University of Alberta in Canada. Dr. Malhotra is triple board-certified in pulmonary disease, sleep medicine and critical care medicine.
Dr. Jeff Armitstead works at ResMed Ltd. as the Vice President of Clinical Science and Innovation. Jeff holds a Ph.D. and engineering degrees from the University of NSW and the Queensland University of Technology and is an Adjunct Professor of Biomedical Engineering at the University of Sydney. Jeff also has training in business strategy from the Drucker school of management. Jeff has over 20 years experience in medical devices and the biomedical engineering field, both in industry and academia. Jeff is published internationally and is the principal or contributing author of many patents.
Dr. Adam Benjafield is the Vice President of Medical Affairs - Sleep at ResMed. He holds a Bachelor of Medical Science and Ph.D. in Medicine from the University of Sydney. He has led over 150 clinical studies ranging from product development to support regulatory approvals through to multi-centre international randomized controlled trials. He leads the ResMed global evidence generation program for Sleep and is leader of the ResMed Science Center. Dr. Benjafield has nearly 20 years of experience in clinical research, in industry and academia, and with his team liaise with top researchers to further the field with a focus on showing the clinical and economic value of treating sleep disordered breathing.
Dr. Liesl Cooper is Vice President, Market Access for ResMed Inc. in San Diego, CA. In this position, she is responsible for supporting and guiding the implementation of healthcare economics, global policy and reimbursement strategies across the Company’s medical devices global business units. This includes ensuring that the costs/benefits of products are understood by payers, policy-makers, governments and physicians, by ensuring leadership in the provision of credible evidence-based data, thought-leadership and policy-maker interaction in collaboration with government and medical affairs.
Liesl has more than 20 years of experience in the healthcare industry. Prior to joining ResMed she was Vice President, Health Economics & Reimbursement at Covidien, and also spent time at Cordis and Eli Lilly and Company. Liesl is also a licensed pharmacist.
Liesl holds a Doctor of Philosophy degree in Pharmaceutical and Health Outcomes Sciences, a Master of Business Administration and a Bachelor of Science in Pharmacy.
Dana Di Ferdinando is ResMed’s Vice President of Advanced Analytics and is responsible for leading the strategy for leveraging ResMed’s informatics platforms to create insights and better outcomes for its customers and patients. Dana brings more than 25 years of experience in informatics within the life sciences and technology industries. She holds a B.S. in Computer Science from Rutgers University and an M.S. in Operations Research from Stanford University.
Dr. Carlos M. Nunez was appointed ResMed’s chief medical officer in January 2017. Prior to joining ResMed, he was senior vice president of Medical Affairs at Becton, Dickinson and Company, leading the Office of Science, Medicine and Technology for its largest division. Before that, he was chief medical officer at CareFusion, where he built and led a global team that provided company-wide medical oversight. From 2000 to 2011, Carlos was chief physician executive at Picis, Inc., an industry-leading medical informatics company that became part of the Optum division of UnitedHealth Group. At Picis/Optum, Carlos provided medical leadership and clinical direction for corporate strategy, marketing, product development, sales, implementation and customer relations for global markets.